feed,title,long_url,short_url
Benzinga,ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory Approval of Aducanumab,https://www.benzinga.com/pressreleases/20/10/g17991009/promis-neurosciences-offers-its-perspective-on-the-likelihood-of-regulatory-approval-of-aducanumab,https://j.mp/2TeG5zm
Benzinga,"ARMOUR Residential REIT, Inc. Announces November 2020 Dividend Rate Per Common Share",https://www.benzinga.com/pressreleases/20/10/g17991005/armour-residential-reit-inc-announces-november-2020-dividend-rate-per-common-share,https://j.mp/37sB2Uc
